http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2633732-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26e19c12ac350fc1c0c02bcf301685e6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_03c4720e107878f494e6eb5a8e8500ea |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C40B30-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6876 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2012-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d191e1b6edaf82ab42299754cc9fed38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86781423100ac4d29321004ba4f13ea3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4da62744bd93a1cd37c96eb76f2a4ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42524495d85d0149dab461d7be6a83f7 |
| publicationDate | 2017-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2633732-T3 |
| titleOfInvention | Procedure and kit to determine in vitro the immune status of an individual |
| abstract | Procedure to determine in vitro the overall immune status of a septic individual for the implementation of the best possible therapy based on the established immune response according to which: a. a blood sample of the individual is available, b. There are at least two specific reagents of at least two expression products of at least two target genes respectively selected from the following target genes: HLA-DRA, S100A9, S100A8, IRAK-M, LY64, CIITA, TNF-alpha, IL -10, GBP1, MMP7, CXCL1, CXCL10, COX2, FCN1, TNFAIP6, CXCL7, CXCL5, PID1 and RHOU, c. the expression of said at least two target genes is determined, and d. the expression of said at least two target genes respectively is compared with a reference expression, a modification in the expression of said at least two target genes with respect to their reference expression being an indicator of a modification of the individual's immune status, and being a correlation between the expression of said at least two target genes with their reference expression an indicator of a normality of the individual's immune status. |
| priorityDate | 2011-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 181.